Genome Scanning Detects Amplification of the Cathepsin B Gene (CtsB) in Transformed Rat Ovarian Surface Epithelial Cells

Abstract

Objective: To isolate a portion of the amplicon inferred to be present in a malignant rat tumor cell line, NuTu 26, by the presence of a homogeneously staining chromosomal region (hsr) and identify genes embedded within it.

Methods: Genome scanning was used to identify an EcoRI fragment (8.6 kbp) within the amplified region of the NuTu 26 genome using a recently identified rat repetitive sequence, OST¹⁷ as a probe. The 8.6 kbp amplified fragment was sequenced and used as starting material to obtain additional sequence information by screening a P1 clone-derived DNA library to identify any genes likely embedded in the amplicon. Use of the microdissected hsr as a probe for fluorescence in situ hybridization (FISH) and application of Southern, Northern, and Western blot analysis confirmed the amplification of this region in the NuTu 26 genome.

Results: The cathepsin B gene was within the amplicon of the hsr-containing marker chromosome of NuTu 26. FISH analysis and chromosomal banding further revealed that the marker chromosome was a derivative of chromosomes 4 and 15, ie, der(15)t(4;15).

Conclusion: Cathepsin B gene amplification may contribute to some aspect of the biology of ovarian cancer. This concept is strengthened by the finding that the gene is overexpressed frequently in independently transformed rat ovarian surface epithelial cells.

Keywords

Cancer ovary cathepsin B tumor invasiveness

Get full access to this article

View all access options for this article.

References

1. Godwin A , Schultz D , Hamilton T , Knudson A . Oncogenes and tumor suppressor genes. In: Hoskins W , Perez C , Young R , eds. Principles and practice of gynecological oncology. Philadelphia, Pennsylvania: J.B. Lippincott Company, 1997:107-148.

2. Miki Y , Swensen J , Shattuck-Eldens D , et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.

3. Futreal P , Liu Q , Shattuck-Eldens D , et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994;266:120-122.

4. Hosking L , Trowsdale J , Nicolai H , et al. A somatic BRCA1 mutation in an ovarian tumor. Nature Genet 1995;9:343-344.

5. Matsushima M , Kobayashi K , Emi M , et al. Mutation analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients: Four germline mutations, but no evidence of somatic mutation. Hum Mol Genet 1995;4:1953-1956.

6. Merajver S , Pham T , Caduff M , et al. Somatic mutations in the BRCA1 gene in sporadic ovarian cancer. Nature Genet 1995;9:439-450.

7. Godwin A , Testa J , Handel L , et al. Spontaneous transformation of rat ovarian surface epithelial cells implicates repeated ovulation in ovarian cancer etiology and is associated with clonal cytogenetic changes. J Natl Cancer Inst 1992;84:592-601.

8. Testa J , Getts L , Salazar H , et al. Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexity. Cancer Res 1994;54:2778-2784.

9. Whittemore A , Harris R , Itnyre J , and the C.O.C.G. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992;36:1184-1203.

10.

10. Negri E , Franceschi S , Tzonou A , et al. Pooled analysis of 3 European case control studies: I. Reproductive factors and the risk of epithelial ovarian cancer. Int J Cancer 1991;49:50-56.

11.

11. Hamilton T . Ovarian cancer. Part I: Biology. Curr Probl Cancer 1992;16:1-57.

12.

12. Fathalla M . Incessant ovulation: A factor in ovarian neoplasia? Lancet 1971;2:163-163.

13.

13. Fathalla M . Factors in the causation and incidence of ovarian cancer. Obstet Gynecol Survey 1972;27:751-768.

14.

14. Abdollahi A , Godwin A , Miller P , et al. Identification of a gene containing zinc-finger motifs based on lost expression in malignantly transformed rat ovarian surface epithelial cells. Cancer Res 1997;57:2029-2034.

15.

15. Abdollahi A , Roberts D , Godwin A . et al. Identification of a zinc-finger gene at 6q25: A chromosomal region implicated in the development of many solid tumors. Oncogene 1997;14:1973-1979.

16.

16. Lin C , Alitalo K , Schwab M , George D , Varmus H , Bishop J . Evolution of karyotypic abnormalities and C-MYC oncogene amplification in human colonic carcinoma cell lines. Chromosoma 1985;92:11-15.

17.

17. Godwin A , Miller P , Getts L , et al. Retroviral-like sequences specifically expressed in the rat ovary detect genetic differences between normal and transformed rat ovarian surface epithelial cells. Endocrinology 1995;136:4640-4649.

18.

18. Schwartz M . Tissue cathepsins as tumor markers. Clin Chim Acta 1995;237:67-78.

19.

19. Keppler D , Sloane BF . Cathepsin B: Multiple enzyme forms from a single gene and their relation to cancer. Enzyme Protein 1996;49:94-105.

20.

20. Kozyreva E , Zhordanina K , Basalyk L , Vasil A . Prognostic significance of determining cathepsin B activity in malignant ovarian tumors. Voproosy Medit Klimii 1994;40:25-27.

21.

21. Brilliant M , Gondo Y , Eicher E . Direct molecular identification of the mouse pink-eyed unstable mutation by genome scanning. Science 1991;252:566-569.

22.

22. Magliocco A , Brilliant M . Genome scanning detects genetic alterations in human ovarian carcinoma. Human Mutation 1994;4:141-149.

23.

23. Makris A , Patriotis C , Bear S , Tschiclis PN . Structure of the Moloney murine leukemia virus-virus-like 30 recombinant: Implications for transduction of c-Ha-ras protooncogene. J Virol 1993;67:1286-1291.

24.

24. Cho K-O , Minnsk B , Wagner JA . NICER elements: A family of nerve growth factor inducible cAMP-extinguishable retroviruslike elements. Proc Natl Acad Sci USA 1990;87:3778-3782.

25.

25. Firulli BA , Anderson GR , Stoler DL , Estes SD . Anoxia-inducible rat VL30 elements and their relationship to ras-containing sarcoma viruses. J Virol 1993;67:6857-6862.

26.

26. Guan X-Y , Meltzer P , Dalton W , Trent J . Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nature Genet 1994;8:155-1111111111161.

27.

27. Guan X-Y , Cargile C , Anzick S , et al. Chromosome microdissection identifies cryptic sites of DNA sequence amplification in human ovarian carcinoma. Cancer Res 1995;55:3380-3385.

28.

28. Kao F . Microdissection and microcloning of human chromosome regions in genome and genetic disease analysis. Bioessays 1993;15:141-146.

29.

29. Ludecke H , Senger G , Claussen U , Horsthemke B . Cloning defined regions of the human genome by microdissection of banded chromosomes and enzymatic amplification. Nature 1989;338:348-350.

30.

30. Taguchi T , Cheng G , Bell D , et al. Combined chromosome microdissection and comparative genomic hybridization detect multiple sites of amplified DNA in a human lung carcinoma cell line. Genes Chromosomes Cancer 1997;20:208-212.

31.

31. Keppler D , Saneni M , Moin K , Mikkelsen T , Diglio C , Sloane B . Tumor progression and angiogenesis: Cathepsin B and company. Biochem Cell Biol 1996;74:799-810.

32.

32. Poole AR , Tiltman KJ , Recklies AD , Stoker TAM . Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas. Nature 1978;273:545-547.

33.

33. Lah TT , Kokali-Kunovar M , Strukeli B , et al. Stefins and lysosomal cathepsins B, L and D in human breast carcinoma. Int J Cancer 1992;50:36-44.

34.

34. Lah TT , Calaf G , Kalman E , et al. Cathepsins B and L, are related to the tumorigenicity of transformed human breast epithelial cells (HBEC). Proc AACR 1994;35:164-164.

35.

35. Buck MR , Roth MJ , Zhuang Z , et al. Increased levels of 72 kilodalton type IV collagenase and cathepsin B in microdissected human breast and colon carcinomas. Proc AACT 1994;35:59-59.

36.

36. Inoue T , Ishida T , Sugio K , Sugimachi K . Cathepsin B expression and laminin degradation as factors influencing prognosis of surgically treated patients with lung adenocarcinoma. Cancer Res 1994;54:6133-6136.

37.

37. Qian F , Chan S-J , Achkar C , Steiner DF , Frankfater A . Transcriptional regulation of cathepsin B expression in B16 melanomas of varying metastatic potential. Biochem Biophys Res Commun 1994;202:429-436.

38.

38. Rempel SA , Rosenblum ML , Mikkelsen T , et al. Cathepsin B expression and localization in glioma progression and invasion. Cancer Res 1994;54:6027-6031.

39.

39. Campo E , Munoz J , Miguel R , et al. Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. Am J Pathol 1994;145:301-309.

40.

40. Jessup JM . Cathepsin B and other proteases in human colorectal carcinoma. Am J Pathol 1994;145:253-253.

41.

41. Iacobuzio C , Shuja S , Cai J , Murnane MJ . Cathepsin B in colorectal tumors: Western blot analyses reveal quantitative and qualitative changes. Proc AACR 1995;36:94-94.

42.

42. Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.

43.

43. Bell D , Yeung R , Bohlander S , Cheng J , Jin F , Testa J . A microdissection library of the rat renal carcinoma gene region. Cytogenet Cell Genet 1995;70:92-94.

44.

44. Bohlander S , Espinosa R , LeBeau M , Rowley J , Diaz M . A method for the rapid sequence-independent amplification of microdissected chromosomal material. Genomics 1992;13:1322-1324.